Tokai Pharmaceuticals Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Tokai Pharmaceuticals Inc
TickerELDN
CIK #0001404281
CUSIP28617K101
SectorLife Sciences - Pharmaceutical Preparations
Address1 Broadway 14th Floor, Cambridge, MA 02142
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Eledon Pharmaceuticals Inc 2024-05-23 50.0 M Exemption: 506(b) · Remaining: Indefinite · Duration: One year or less · Commission: $1,617,174 · Revenue: No Revenues
Novus Therapeutics Inc 2020-09-25 108.1 M Exemption: 506(b) · Minimum: $498 · Duration: One year or less · Commission: $4,123,597 · Revenue: Decline to Disclose
Tokai Pharmaceuticals Inc 2013-05-15 20.0 M Exemption: 506 · Remaining: $15,499,992 · Duration: One year or less · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001404281] 10-K
[0001404281] 10-Q
[0001404281] 3
[0001404281] 4
[0001404281] 8-K
[0001404281] D
[0001404281] SC 13D
[0001404281] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
BlackRock Inc Eledon Pharmaceuticals Inc [2026-04-27] 0.0
Coastlands Capital LP Eledon Pharmaceuticals Inc [2025-11-24] 0.0
Vanguard Group Inc Eledon Pharmaceuticals Inc [2025-07-29] 0.0
BlackRock Inc Eledon Pharmaceuticals Inc [2025-07-17] 0.0
RA Capital Management LP Eledon Pharmaceuticals Inc [2024-11-05] 6.1
Frazier Life Sciences Public Fund LP Eledon Pharmaceuticals Inc [2024-11-05] 81944.6
Armistice Capital LLC Eledon Pharmaceuticals Inc [2024-02-14] 0.99
Woodline Partners LP Eledon Pharmaceuticals Inc [2021-02-16] 5.4
FMR LLC Eledon Pharmaceuticals Inc [2021-02-08] 0.0
Adage Capital Partners GP LLC Eledon Pharmaceuticals Inc [2021-01-04] 5.89
Cormorant Asset Management LP Eledon Pharmaceuticals Inc [2021-01-04] 9.89
Logos Global Management LP Novus Therapeutics Inc [2020-11-09] 15.7
683 Capital Management LLC Novus Therapeutics Inc [2019-07-26] 8.8
Armistice Capital LLC Novus Therapeutics Inc [2019-06-05] 4.99
Biotechnology Value Fund L P Novus Therapeutics Inc [2019-05-10] 6.1
Lifesci Index Partners LLC Novus Therapeutics Inc [2018-03-13] 5.31
Nussbaum Ran Novus Therapeutics Inc [2017-05-25] 7.7
Peregrine Ventures Management Ltd Novus Therapeutics Inc [2017-05-22] 8.9
OrbiMed Israel BioFund GP Limited Partnership Novus Therapeutics Inc [2017-05-19] 36.2
OTIC Pharma Ltd Tokai Pharmaceuticals Inc [2017-01-05] 39.3
Satter Muneer A Tokai Pharmaceuticals Inc [2015-02-12] 7.9
Novo A/S Tokai Pharmaceuticals Inc [2014-10-22] 5.1
Novartis BioVentures Ltd Tokai Pharmaceuticals Inc [2014-10-01] 21.3
Apple Tree Partners II LP Tokai Pharmaceuticals Inc [2014-09-30] 34.7
Form 3/4/5 Filer 2011 - 2026
Tokai Pharmaceuticals Inc
McBride John S
Robinson James A Jr
Lee June
Katkin Keith
Kirk Allan
Hillson Jan
Smith Bryan E
Gros David-Alexandre C
Little Paul Sean
Perrin Steven
BVF Inc/IL
Biotechnology Value Trading Fund OS LP
BVF Partners L P/IL
Lampert Mark N
BVF GP Holdings LLC
BVF II GP LLC
BVF Partners OS Ltd
Biotechnology Value Fund L P
Biotechnology Value Fund II LP
BVF I GP LLC
Lyons Gary A
Ogier Walter C
OrbiMed Israel GP Ltd
OrbiMed Israel BioFund GP Limited Partnership
Logos Global Management LP
Kuwahara Jon
Turkel Catherine C
Flesher Gregory J
Chimovits Erez
Cohen Cheryl
Lifesci Index Partners LLC
YOOK Paul
Morrison Jodie Pope
Ocampo Christine
Buckley Stephen Jr
Harrison Seth Loring
Barberich Timothy J
Yanchik Joseph A III
Kessler David A
Ferrante Karen Jean
Kalowski Lee
Quirk Gerald E
Novartis AG
Novartis BioVentures Ltd
Satter Muneer A
ATP Life Science Ventures LP
Apple Tree Partners II - Annex LP
Apple Tree Partners II LP
Thomas Robert Bain
Wade Denis Newell
Williams Martin D
Warman Investments Pty Ltd
Stewart Susan B
QBF No 2 Pty Ltd as trustee for Queensland BioCapital Fund
QBF No 1 Pty Ltd as trustee for Queensland BioCapital Fund
Platt Jon B
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
McBride John S
Common Stock
2026-01-10 Option exercise 3,430 $0.00
Katkin Keith
Common Stock
2026-01-10 Option exercise 8,575 $0.00
Hillson Jan
Common Stock
2026-01-10 Option exercise 3,430 $0.00
Kirk Allan
Common Stock
2026-01-10 Option exercise 3,430 $0.00
Lee June
Common Stock
2026-01-10 Option exercise 3,430 $0.00
Robinson James A Jr
Common Stock
2026-01-10 Option exercise 3,430 $0.00
McBride John S
Restricted Stock Units · derivative
2026-01-10 Option exercise 3,430 $0.00
Hillson Jan
Restricted Stock Units · derivative
2026-01-10 Option exercise 3,430 $0.00
Kirk Allan
Restricted Stock Units · derivative
2026-01-10 Option exercise 3,430 $0.00
Katkin Keith
Restricted Stock Units · derivative
2026-01-10 Option exercise 8,575 $0.00
Lee June
Restricted Stock Units · derivative
2026-01-10 Option exercise 3,430 $0.00
Robinson James A Jr
Restricted Stock Units · derivative
2026-01-10 Option exercise 3,430 $0.00
Hillson Jan
Restricted Stock Units · derivative
2025-01-10 Grant 3,430 $0.00
Hillson Jan
Stock Option (right to buy) · derivative
2025-01-10 Grant 30,870 $0.00
McBride John S
Restricted Stock Units · derivative
2025-01-10 Grant 3,430 $0.00
McBride John S
Stock Option (right to buy) · derivative
2025-01-10 Grant 30,870 $0.00
Gros David-Alexandre C
Restricted Stock Units · derivative
2025-01-10 Grant 66,500 $0.00
Gros David-Alexandre C
Stock Option (right to buy) · derivative
2025-01-10 Grant 600,000 $0.00
Smith Bryan E
Stock Option (right to buy) · derivative
2025-01-10 Grant 150,500 $0.00
Smith Bryan E
Restricted Stock Units · derivative
2025-01-10 Grant 64,500 $0.00
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 123 42,711,035
2025-12-31 96 44,244,525
2025-09-30 84 36,852,767
2025-06-30 86 40,962,206
2025-03-31 84 38,413,039
2024-12-31 76 38,512,727
2024-09-30 34 18,485,924
2024-06-30 33 18,859,941
2024-03-31 30 9,601,367
2023-12-31 30 9,156,821
2023-09-30 29 8,917,867
2023-06-30 34 9,280,310
Form 13F Holdings
Firm Period DFND Voting Shares
Prodigy Asset Management LLC [2026-06-30] SOLE 0 86,703
Wealth Enhancement Advisory Services LLC [2026-06-30] SOLE 840 34,615
Howard Financial Services Ltd [2026-06-30] SOLE 0 30,000
Relyea Zuckerberg Hanson LLC [2026-06-30] SOLE 0 17,000
Revolve Wealth Partners LLC [2026-06-30] SOLE 0 14,143
GK Wealth Management LLC [2026-06-30] DFND 0 11,487
Everhart Financial Group Inc [2026-06-30] SOLE 0 10,000
Farmers & Merchants Investments Inc [2026-06-30] SOLE 6,321 6,321
Merit Financial Group LLC [2026-06-30] SOLE 16 5,718
Merit Financial Group LLC [2026-06-30] OTR 0 5,414
MassMutual Private Wealth & Trust FSB [2026-06-30] SOLE 1,305 1,305
Gamma Investing LLC [2026-06-30] DFND 1,188 1,188
Farther Finance Advisors LLC [2026-06-30] SOLE 0 637
True Wealth Design LLC [2026-06-30] SOLE 0 494
Fortitude Family Office LLC [2026-06-30] SOLE 59 59
IFP Advisors LLC [2026-06-30] SOLE 8 8
Byrne Asset Management LLC [2026-06-30] SOLE 1 1
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com